These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15910857)

  • 1. Mutations in MTP gene in abeta- and hypobeta-lipoproteinemia.
    Di Leo E; Lancellotti S; Penacchioni JY; Cefalù AB; Averna M; Pisciotta L; Bertolini S; Calandra S; Gabelli C; Tarugi P
    Atherosclerosis; 2005 Jun; 180(2):311-8. PubMed ID: 15910857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-function analyses of microsomal triglyceride transfer protein missense mutations in abetalipoproteinemia and hypobetalipoproteinemia subjects.
    Walsh MT; Di Leo E; Okur I; Tarugi P; Hussain MM
    Biochim Biophys Acta; 2016 Nov; 1861(11):1623-1633. PubMed ID: 27487388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypobetalipoproteinemia with an apparently recessive inheritance due to a "de novo" mutation of apolipoprotein B.
    Lancellotti S; Di Leo E; Penacchioni JY; Balli F; Viola L; Bertolini S; Calandra S; Tarugi P
    Biochim Biophys Acta; 2004 Jan; 1688(1):61-7. PubMed ID: 14732481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel mutations in SAR1B and MTTP genes in Tunisian children with chylomicron retention disease and abetalipoproteinemia.
    Magnolo L; Najah M; Fancello T; Di Leo E; Pinotti E; Brini I; Gueddiche NM; Calandra S; Slimene NM; Tarugi P
    Gene; 2013 Jan; 512(1):28-34. PubMed ID: 23043934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of patients with abetalipoproteinemia and homozygous familial hypobetalipoproteinemia in Tunisia.
    Najah M; Di Leo E; Awatef J; Magnolo L; Imene J; Pinotti E; Bahri M; Barsaoui S; Brini I; Fekih M; Slimane MN; Tarugi P
    Clin Chim Acta; 2009 Mar; 401(1-2):51-6. PubMed ID: 19056372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel mutations in abetalipoproteinaemia and homozygous familial hypobetalipoproteinaemia.
    Vongsuvanh R; Hooper AJ; Coakley JC; Macdessi JS; O'Loughlin EV; Burnett JR; Gaskin KJ
    J Inherit Metab Dis; 2007 Nov; 30(6):990. PubMed ID: 18027103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using genetically engineered mice to understand apolipoprotein-B deficiency syndromes in humans.
    Raabe M; Kim E; Véniant M; Nielsen LB; Young SG
    Proc Assoc Am Physicians; 1998; 110(6):521-30. PubMed ID: 9824535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microsomal triglyceride transfer protein (MTP) gene mutations in Canadian subjects with abetalipoproteinemia.
    Wang J; Hegele RA
    Hum Mutat; 2000 Mar; 15(3):294-5. PubMed ID: 10679949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of Tunisian families with abetalipoproteinemia and identification of a novel mutation in MTTP gene.
    Najah M; Youssef SM; Yahia HM; Afef S; Awatef J; Saber H; Fadhel NM; Sassolas A; Naceur SM
    Diagn Pathol; 2013 Apr; 8():54. PubMed ID: 23556456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mild case of abetalipoproteinaemia in association with subclinical hypothyroidism.
    Al-Mahdili HA; Hooper AJ; Sullivan DR; Stewart PM; Burnett JR
    Ann Clin Biochem; 2006 Nov; 43(Pt 6):516-9. PubMed ID: 17132287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin E and oxidative stress in abetalipoproteinemia and familial hypobetalipoproteinemia.
    Burnett JR; Hooper AJ
    Free Radic Biol Med; 2015 Nov; 88(Pt A):59-62. PubMed ID: 26086616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Four novel mutations in APOB causing heterozygous and homozygous familial hypobetalipoproteinemia.
    Whitfield AJ; Marais AD; Robertson K; Barrett PH; van Bockxmeer FM; Burnett JR
    Hum Mutat; 2003 Aug; 22(2):178. PubMed ID: 12872264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel mutations in the microsomal triglyceride transfer protein gene causing abetalipoproteinemia.
    Ohashi K; Ishibashi S; Osuga J; Tozawa R; Harada K; Yahagi N; Shionoiri F; Iizuka Y; Tamura Y; Nagai R; Illingworth DR; Gotoda T; Yamada N
    J Lipid Res; 2000 Aug; 41(8):1199-204. PubMed ID: 10946006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homozygous familial hypobetalipoproteinemia: two novel mutations in the splicing sites of apolipoprotein B gene and review of the literature.
    Cefalù AB; Norata GD; Ghiglioni DG; Noto D; Uboldi P; Garlaschelli K; Baragetti A; Spina R; Valenti V; Pederiva C; Riva E; Terracciano L; Zoja A; Grigore L; Averna MR; Catapano AL
    Atherosclerosis; 2015 Mar; 239(1):209-17. PubMed ID: 25618028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial hypobetalipoproteinemia caused by a mutation in the apolipoprotein B gene that results in a truncated species of apolipoprotein B (B-31). A unique mutation that helps to define the portion of the apolipoprotein B molecule required for the formation of buoyant, triglyceride-rich lipoproteins.
    Young SG; Hubl ST; Smith RS; Snyder SM; Terdiman JF
    J Clin Invest; 1990 Mar; 85(3):933-42. PubMed ID: 2312735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homozygous MTTP and APOB mutations may lead to hepatic steatosis and fibrosis despite metabolic differences in congenital hypocholesterolemia.
    Di Filippo M; Moulin P; Roy P; Samson-Bouma ME; Collardeau-Frachon S; Chebel-Dumont S; Peretti N; Dumortier J; Zoulim F; Fontanges T; Parini R; Rigoldi M; Furlan F; Mancini G; Bonnefont-Rousselot D; Bruckert E; Schmitz J; Scoazec JY; Charrière S; Villar-Fimbel S; Gottrand F; Dubern B; Doummar D; Joly F; Liard-Meillon ME; Lachaux A; Sassolas A
    J Hepatol; 2014 Oct; 61(4):891-902. PubMed ID: 24842304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypobetalipoproteinemia: genetics, biochemistry, and clinical spectrum.
    Tarugi P; Averna M
    Adv Clin Chem; 2011; 54():81-107. PubMed ID: 21874758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of fatty liver disease and plasma lipoproteins in a kindred with familial hypobetalipoproteinemia due to a novel truncated form of apolipoprotein B (APO B-54.5).
    Tarugi P; Lonardo A; Ballarini G; Erspamer L; Tondelli E; Bertolini S; Calandra S
    J Hepatol; 2000 Sep; 33(3):361-70. PubMed ID: 11019990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular diagnosis of hypobetalipoproteinemia: an ENID review.
    Tarugi P; Averna M; Di Leo E; Cefalù AB; Noto D; Magnolo L; Cattin L; Bertolini S; Calandra S
    Atherosclerosis; 2007 Dec; 195(2):e19-27. PubMed ID: 17570373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complex genetic architecture in severe hypobetalipoproteinemia.
    Wang LR; McIntyre AD; Hegele RA
    Lipids Health Dis; 2018 Mar; 17(1):48. PubMed ID: 29540175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.